This trial is active, not recruiting.

Conditions esophageal cancer, stomach cancer, pancreatic cancer
Treatments standard follow-up, pet/ct and eus
Sponsor Michael Bau Mortensen
Collaborator Odense University Hospital
Start date April 2011
End date January 2016
Trial size 182 participants
Trial identifier NCT02209415, 2011-41-5702


Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic.

This is because the methods and the consequence of following these patients is unknown.

Therefore the investigators will randomize these patients in to two groups:

1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department.

2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose diagnostic
(Active Comparator)
Outpatient clinic visits 3,6,9,12,18 and 24 mths after surgery
standard follow-up
Outpatient clinic visits
PET/CT and EUS at 3,6,9,12,18 and 24 months after surgery
pet/ct and eus

Primary Outcomes

Number of patients eligible for treatment
time frame: 2 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - R0- resection for primary adenocarcinoma or squamous cell carcinoma of the esophagus, stomach or pancreas.

Additional Information

Official title Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.
Trial information was received from ClinicalTrials.gov and was last updated in August 2014.
Information provided to ClinicalTrials.gov by Odense University Hospital.